Lexicon Pharmaceuticals 和 Lexeo Therapeutics 分别通过超额认购的私募融资筹集了 2.5 亿美元和 9500 万美元。 Lexicon Pharmaceuticals and Lexeo Therapeutics each raise $250M and $95M in oversubscribed private placements.
Lexicon Pharmaceuticals 和 Lexeo Therapeutics 分别宣布超额认购私募，总额分别为 2.5 亿美元和 9500 万美元。 Lexicon Pharmaceuticals and Lexeo Therapeutics each announced oversubscribed private placements totaling $250M and $95M, respectively. Lexicon 计划向合格投资者发行 A 系列可转换优先股，而 Lexeo Therapeutics 将向机构和医疗保健投资者出售普通股。 Lexicon plans to issue Series A Convertible Preferred Stock to accredited investors, while Lexeo Therapeutics will sell common stock to institutional and healthcare investors. 两项私募都旨在扩大各自公司的业务范围并支持其正在进行的临床项目。 Both private placements aim to extend their respective companies' runways and support their ongoing clinical programs.